GlassScriptPhysician profile
Ramona N Coffie
NPI 1235391566
$3,803.46
in general payments reported to CMS, 2019-2025
37 companies · $871 in 2025
The $871 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $203 · 2021: $103 · 2022: $471 · 2023: $833 · 2024: $958 · 2025: $871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,661.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $607.40 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Novo Nordisk INC | $363.79 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $353.79 | 2019-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $340.62 | 2019-2025 | Trelegy Ellipta, Shingrix, Bexsero |
| Pfizer INC. | $292.75 | 2019-2025 | |
| Astellas Pharma US INC | $252.52 | 2019-2025 | Veozah |
| Lilly USA, LLC | $208.69 | 2019-2025 | Mounjaro, Zepbound, Emgality |
| Bayer Healthcare Pharmaceuticals INC. | $139.61 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $112.97 | 2020-2025 | |
| Idorsia Pharmaceuticals US INC | $99.76 | 2023-2024 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $85.23 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $80.36 | 2020-2025 | Breztri, Farxiga, Airsupra |
| Otsuka America Pharmaceutical, INC. | $77.08 | 2023-2024 | Rexulti |
| Allergan, INC. | $71.86 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.95 | 2019-2023 | Jardiance |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramona Coffie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.